<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001276</url>
  </required_header>
  <id_info>
    <org_study_id>910066</org_study_id>
    <secondary_id>91-DK-0066</secondary_id>
    <nct_id>NCT00001276</nct_id>
  </id_info>
  <brief_title>Diagnosing and Treating Low Blood Sugar Levels</brief_title>
  <official_title>Fasting Hypoglycemia: Diagnosis and Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study&#xD;
      will continue to research the causes of hypoglycemia.&#xD;
&#xD;
      Patients involved in the study will be admitted to the Clinical Center of the National&#xD;
      Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required&#xD;
      to refrain from eating for a set period of time and will undergo blood tests for insulin&#xD;
      levels and several other specific diagnostic tests related to insulin secretion. The patients&#xD;
      will be under supervision and will be provided with appropriate medical and surgical&#xD;
      attention as needed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this protocol is to continue our studies of the evaluation and treatment of&#xD;
      patients with fasting hypoglycemia due to diverse etiologies. Patients will be admitted to&#xD;
      the Clinical Research Center under this protocol and undergo supervised fasting, dynamic&#xD;
      tests of insulin secretion when appropriate, medically indicated imaging studies, and&#xD;
      appropriate medical and surgical treatment.&#xD;
&#xD;
      The goals of this study are:&#xD;
&#xD;
        1. To understand the pathophysiology and various causes of hypoglycemia (e.g.,insulinomas,&#xD;
           MEN1, MEN2).&#xD;
&#xD;
        2. To identify new circulating biomarkers of insulinomas.&#xD;
&#xD;
        3. To create a repository of clinical data and samples for future research of insulinomas.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 17, 1995</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Outcomes</measure>
    <time_frame>every 1-3 months</time_frame>
    <description>resolution of hypoglycemia</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Hypoglycemia</condition>
  <condition>Insulinoma</condition>
  <arm_group>
    <arm_group_label>Patients with hypoglycemia</arm_group_label>
    <description>Patients with hypoglycemia due to diverse etiologies.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients how are referred to us that have fasting hypoglycemia due to diverse&#xD;
        etiologies.@@@@@@&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        In order to be eligible to participate in this study, an individual must meet all of the&#xD;
        following criteria:&#xD;
&#xD;
          1. Male, females ages &gt;= 18.&#xD;
&#xD;
          2. Patients with documented fasting blood glucose below 55 mg/dl.&#xD;
&#xD;
        4. Patients with biochemical evidence for insulinoma or other neuroendocrine tumors.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        An individual who meets any of the following criteria will be excluded from participation&#xD;
        in this study:&#xD;
&#xD;
          1. Patients with known sulfa allergies and patients with significant cardiac disease will&#xD;
             be excluded.&#xD;
&#xD;
          2. Subjects who are pregnant.&#xD;
&#xD;
          3. Medically unstable per the assessment of the PI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ranganath Muniyappa, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Craig S Cochran, R.N.</last_name>
    <phone>(301) 402-1880</phone>
    <email>craigc@bdg10.niddk.nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ranganath Muniyappa, M.D.</last_name>
    <phone>(301) 451-7702</phone>
    <email>muniyapr@mail.nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1991-DK-0066.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Bar RS, Gorden P, Roth J, Siebert CW. Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J Clin Endocrinol Metab. 1977 Jun;44(6):1210-3. doi: 10.1210/jcem-44-6-1210.</citation>
    <PMID>194912</PMID>
  </reference>
  <reference>
    <citation>Blackshear PJ, Rotner HE, Kriauciunas KA, Kahn CR. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med. 1983 Aug;99(2):182-4. doi: 10.7326/0003-4819-99-2-182.</citation>
    <PMID>6349454</PMID>
  </reference>
  <reference>
    <citation>Comi RJ, Gorden P. Approach to hypoglycemia in adults. Compr Ther. 1987 Mar;13(3):38-44. No abstract available.</citation>
    <PMID>3568598</PMID>
  </reference>
  <verification_date>January 21, 2023</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>January 25, 2023</last_update_submitted>
  <last_update_submitted_qc>January 25, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypoglycemia</keyword>
  <keyword>Insulinoma</keyword>
  <keyword>Natural History</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulinoma</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

